B, B., JS, H., K, H., R, M., & YX, Y. (2021). Digoxin use is associated with pancreatic cancer risk but does not affect survival. Cancer causes & control : CCC, 32(1), 41. https://doi.org/10.1007/s10552-020-01352-7
Chicago Style (17th ed.) CitationB, Boursi, Huber JS, Haynes K, Mamtani R, and Yang YX. "Digoxin Use Is Associated with Pancreatic Cancer Risk but Does Not Affect Survival." Cancer Causes & Control : CCC 32, no. 1 (2021): 41. https://doi.org/10.1007/s10552-020-01352-7.
MLA (9th ed.) CitationB, Boursi, et al. "Digoxin Use Is Associated with Pancreatic Cancer Risk but Does Not Affect Survival." Cancer Causes & Control : CCC, vol. 32, no. 1, 2021, p. 41, https://doi.org/10.1007/s10552-020-01352-7.
Warning: These citations may not always be 100% accurate.